Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Study ID: NCT06262516
Start Date: 2024-05-17
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

94

Intervention / Treatment

Nephroureterectomy

Lymph Node Dissection

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Study ID: NCT04975516
Start Date: 2023-07-18
End Date: 2027-07-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

54

Intervention / Treatment

Chemotherapy

Stereotactic Body Radiation Therapy

Computed Tomography

Magnetic Resonance Imaging

Biospecimen Collection

Administration questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

7-Days Water-Only Fasting Trial in Prostate Cancer

Study ID: NCT06826924
Start Date: 2025-06-03
End Date: 2026-06-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Fasting

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Study ID: NCT05081024
Start Date: 2021-09-03
End Date: 2025-09-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Biopsy

Biospecimen Collection

Electronic Health Record Review

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

Study ID: NCT03926624
Start Date: 2019-11-22
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase3

No. of Participants

450

Intervention / Treatment

DFP-10917

Cytarabine

Azacitidine

Decitabine

Mitoxantrone

Etoposide

Fludarabine

Again

Venetoclax

Cladribine

Sponsor

Delta-Fly Pharma, Inc.

Source: clinicaltrials.gov

Share:
Add to list

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Study ID: NCT05351424
Start Date: 2022-05-03
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

194

Intervention / Treatment

Audiovisual Intervention- Radiation Therapy Education

ASTRO Radiation Therapy for Breast or Prostate Cancer Brochure

Audiovisual Intervention- Cancer Clinical Trials Education

NCI Taking Part in Cancer Research Studies Brochure

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

Study ID: NCT05624996
Start Date: 2023-07-12
End Date: 2031-10-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

474

Intervention / Treatment

Carboplatin

Cisplatin

Computed Tomography

Durvalumab

Etoposide

Image Guided Radiation Therapy

Nab-paclitaxel

Paclitaxel

Pemetrexed

Positron Emission Tomography

Administration questionnaire

Stereotactic Body Radiation Therapy

Sponsor

NRG Oncology

Source: clinicaltrials.gov

Share:
Add to list

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Study ID: NCT05397496
Start Date: 2022-10-03
End Date: 2028-06-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

140

Intervention / Treatment

PIT565

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Study ID: NCT05119296
Start Date: 2022-02-15
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Pembrolizumab (Keytruda)

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

Study ID: NCT06428396
Start Date: 2024-11-27
End Date: 2028-10-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Belzutifan

Fulvestrant

Everolimus

Exemestane

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list